IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 72 filers reported holding IMMUNE DESIGN CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $390,000 | – | 100,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,208,210 | $16,738,232,000 | 18.66% |
| ProQuest Associates IV LLC | 1,962,720 | $14,877,000 | 4.10% |
| BVF INC/IL | 1,200,000 | $9,096,000 | 1.71% |
| Abingworth LLP | 197,300 | $1,494,000 | 1.43% |
| NEXTHERA CAPITAL LP | 305,000 | $2,312,000 | 1.42% |
| Cormorant Asset Management, LP | 432,990 | $3,282,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 203,000 | $1,539,000 | 0.25% |
| DAFNA Capital Management LLC | 40,000 | $303,000 | 0.21% |
| Monashee Investment Management LLC | 50,000 | $379,000 | 0.13% |
| Eventide Asset Management | 180,000 | $1,364,000 | 0.08% |